‌

US Patent 10695127 Nanoelectroablation control and vaccination

Patent 10695127 was granted and assigned to Pulse Biosciences on June, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Pulse Biosciences

Current Assignee

Pulse Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

106951270

Date of Patent

June 30, 2020

Patent Application Number

163846760

Date Filed

April 15, 2019

Patent Citations

‌

US Patent 10058383 Nanoelectroablation control and vaccination

‌

US Patent 10137152 Inoculation by applying nanosecond pulsed electric fields to a biopsy and reintroducing the treated biopsy to the subject

Patent Citations Received

‌

US Patent 12117272 Method and system for ultra-wideband electromagnetic source

Patent Primary Examiner

‌

Christopher Koharski

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10695127 Nanoelectroablation control and vaccination

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API